2011-2012 - IRCM

American Society of Hypertension & Hypertension
Canada), Alliston, Ontario
Hypertension artérielle réfractaire, Forum en médecine
familiale 2011, Montréal, Québec
La Société québécoise d’hypertension artérielle : 20 ans
de réalisations… 1992-2012 / Recherche Clinique, 20 e
Réunion scientifique annuelle de la Société
québécoise d’hypertension artérielle, Québec, Québec
Thiazides : Bénéfices cardiovasculaires prouvés – Effet de
classe ou effet de la chlorthalidone? 20 e Réunion
scientifique annuelle de la société québécoise
d’hypertension artérielle, Québec, Québec
Modérateur – Symposium « Échange sur le diabète
international », Montréal, Québec
Active research in nephrology: refractory arterial
hypertension, 9 th Annual Nephrology Educator Forum,
Montréal, Québec
Éric LÉCUYER
Messenger RNA nuclear retention as a novel facet of the
DNA damage response, 53 rd Drosophila Research
Conference, Chicago, Illinois
Tarik MÖRÖY
Growth factor independence 1 (Gfi136N) predisposes to
acute myeloid leukemia by including genome-wide
epigenetic changes in oncogenes such as Hoxa9, 53 rd
Annual Meeting of the American Society of
Hematology, San Francisco, Californie
Katrina PODSYPANINA
Regulating oncogenes in mice to model cures in patients,
23 e colloque de l’IFSBM : Environnement et cancer,
Institut de cancérologie Gustave Roussy, Villejuif,
France
Rémi RABASA-LHORET
Le but dans le diabète de type 2: contrôler la glycémie et le
poids sans causer d’hypoglycémie, Symposium
francophone de médecine (réalisation de médecins
francophones du Canada), Montréal, Québec
Symposium « Today on talk type 2: GLP-1 analogues,
DPP-inhibitors and your type 2 diabetes patients », Family
Medicine Forum, Montréal, Québec
La prise en charge du diabète : les nouveautés et les
avenues futures, Association Diabète Québec, Québec,
Québec
Activité physique et diabète de type 1 – Programme de
recherche de l’IRCM, Congrès Diabète Québec, Québec
Modérateur lors du Congrès Diabète Montréal, Montréal,
Québec
Should we introduce insulin before cystic fibrosis related
diabetes diagnosis? Canadian Respiratory Conference
“A Breath of Fresh Air”, Vancouver, Colombie-
Britannique
Understanding the role of GLP-1 agonists in type 2
diabetes, Cardio-Metabolic Summit, Montréal, Québec
When metformin is not enough: How to choose a second
agent? Cardio-Metabolic Summit, Montréal, Québec
Insulin sensitive vs insulin resistant obesity, European
Group for the Study of Insulin Resistance (EGIR)
Meeting 2012, Lyon, France
François ROBERT
A universal RNA polymerase II CTD cycle is orchestrated
by complex interplays between kinase, hosphatase and
isomerase enzymes along genes, CSH Meeting on
Mechanisms of eukaryotic transcription,Cold Spring
Harbor, New York
Peter W. SCHILLER
Bifunctional peptides with a µ/δ opioid activity profile as
analgesic drug candidates with reduced side effects, 12 th
Chinese International Peptide Symposium (CPS-2012),
Shenyang, Chine
Nabil G. SEIDAH
Is reduction of PCSK9 levels a promising therapy for
atherosclerosis?: in vivo models and novel approaches to
silence PCSK9, National Atherosclerosis Forum,
Montréal, Québec
Novel insights into the physiological functions of the
proprotein convertases, 7 th General Meeting of the
International Proteolysis Society, San Diego, Californie
The physiological roles of PCSK9 and its targeting
strategies for lipid lowering, Workshop on Novel lipidlowering
strategies, XVI International Symposium on
Atherosclerosis, Sydney, Australie
61